About this project

Specialties investment of € 18 mln by Lanxess AG at Chempark Krefeld-Uerdingen in Germany, Europe, targeting the production of Trimethylolpropane and Formalin.

Investment details

Park Chempark Krefeld-Uerdingen (DE)
Amount € 18 mln
Categories Specialties
Investors
Target substances
Formalin Product